Skip to main content
SpringerLink
Log in

Optimal Use of Sandimmun® in Nephrotic Syndrome

  • Book
  • © 1992

Overview

Authors:
  1. A. Meyrier

    1. Department of Nephrology and Hypertension Hôpital Avicenne Faculté de Médecine de Bobigny, Université Paris-Nord, Bobigny, France

    View author publications

    You can also search for this author in PubMed   Google Scholar

  2. P. Niaudet

    1. Department of Nephrology, Hôpital Necker-Enfants-Malades, Paris, France

    View author publications

    You can also search for this author in PubMed   Google Scholar

  3. J. Brodehl

    1. Department of Pediatric Nephrology, Medizinische Hochschule, Hannover, Germany

    View author publications

    You can also search for this author in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

  1. Front Matter

    Pages i-vi
    Download chapter PDF

  2. Introduction

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 1-1

  3. Background

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 2-6

  4. Idiopathic nephrotic syndrome (nephrosis)

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 7-24

  5. Idiopathic membranous glomerulopathy

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 25-27

  6. Sandimmun in other etiologies of nephrotic syndrome

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 28-29

  7. Guidelines for the use of Sandimmun in nephrotic syndrome

    • A. Meyrier, P. Niaudet, J. Brodehl
    Pages 30-32

  8. Back Matter

    Pages 33-34
    Download chapter PDF
Back to top

Keywords

About this book

Since 1978, when Sandimmun was first used in humans, great experience has been gathered in clinical transplantation by the treatment of about half a million patients. The experience with Sandimmun in nephrotic syndrome is put into perspective and compared with alternatives such as corticosteroids and cytotoxic agents. Sandimmun may be regarded as a leap forward in the treatment of that population of patients that do not satisfactorily respond to steroids. The possibility of drastically reducing the use of corticosteroids, particularly in children, is perhaps the most attractive feature of Sandimmun. This book gives the results ofa worldwide clinical programme. It includes authors' personal experience as well as an analysis of all data made available. A careful assessment of reported side effects is also given.

Authors and Affiliations

  • Department of Nephrology and Hypertension Hôpital Avicenne Faculté de Médecine de Bobigny, Université Paris-Nord, Bobigny, France

    A. Meyrier

  • Department of Nephrology, Hôpital Necker-Enfants-Malades, Paris, France

    P. Niaudet

  • Department of Pediatric Nephrology, Medizinische Hochschule, Hannover, Germany

    J. Brodehl

Bibliographic Information

  • Book Title: Optimal Use of Sandimmun® in Nephrotic Syndrome

  • Authors: A. Meyrier, P. Niaudet, J. Brodehl

  • DOI: https://doi.org/10.1007/978-3-642-77310-5

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Sandoz Ltd, Basle and Springer-Verlag Berlin Heidelberg 1992

  • Softcover ISBN: 978-3-540-55180-5Due: 16 June 1992

  • eBook ISBN: 978-3-642-77310-5Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VI, 34

  • Number of Illustrations: 10 b/w illustrations

  • Topics: Nephrology, Pharmacology/Toxicology, Allergology, Immunology

Publish with us

Policies and ethics

Back to top

Search

Navigation